Literatur
-
1
Baur-Melnyk A, Reiser M.
Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography.
Radiologe.
2004;
44
874-881
-
2
Durie B G, Kyle R A, Belch A. et al .
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.
Hematol J.
2004;
5
285
-
3
Greipp P R.
Advances in the diagnosis and management of myeloma.
Semin Hematol.
1992;
29
(Suppl 2)
24-45
-
4
Hallek M, Bergsagel P L, Anderson K C.
Multiple myeloma: increasing evidence for a multistep transformation process.
Blood.
1998;
91
3-21
-
5
Hideshima T, Bergsagel P L, Kuehl W M, Anderson K C.
Advances in biology of multiple myeloma: clinical applications.
Blood.
2004;
104
607-618
-
6
Kyle R A, Therneau T M, Rajkumar S V. et al .
A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
N Engl J Med.
2002;
346
564-569
-
7
Moehler T M, Neben K, Ho A D, Goldschmidt H.
Angiogenesis in hematologic malignancies.
Ann Hematol.
2001;
80
695-705
-
8
Riedel D A, Pottern L M.
The epidemiology of multiple myeloma.
Hematol Oncol Clin North Am.
1992;
6
225-247
-
9
Ropper A H, Gorson K C.
Neuropathies associated with paraproteinemia.
N Engl J Med.
1998;
338
1601-1607
-
10
Seidl S, Kaufmann H, Drach J.
New insights into the pathophysiology of multiple myeloma.
Lancet Oncol.
2003;
4
557-564
-
11
Sirohi B, Powles R.
Multiple myeloma.
Lancet.
2004;
363
875-887
Dr. med. Roland Schroers
Georg-August-Universität Göttingen, Zentrum Innere Medizin, Abteilung Hämatologie und Onkologie
Robert Koch-Straße 40
37075 Göttingen
Phone: 0551/398535
Fax: 0551/398587
Email: R.Schroers@medizin.uni-goettingen.de
